| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/19/2002 | WO2002072762A2 Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture |
| 09/19/2002 | WO2002072758A2 Cytochrome p450s and uses thereof |
| 09/19/2002 | WO2002072750A1 Bio-reactor for tissue cultivated in the form of a thin layer and uses thereof |
| 09/19/2002 | WO2002072634A2 Recombinant proteinase k |
| 09/19/2002 | WO2002072632A2 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
| 09/19/2002 | WO2002072631A2 Mhc molecule constructs and their usesfor diagnosis and therapy |
| 09/19/2002 | WO2002072630A2 Nucleic acid-associated proteins |
| 09/19/2002 | WO2002072626A2 Novel form of the phgpx protein as a diagnostic marker for male infertility |
| 09/19/2002 | WO2002072607A2 Soluble heterodimeric cytokine receptor |
| 09/19/2002 | WO2002072605A2 Expression technology for proteins containing a hybrid isotype antibody moiety |
| 09/19/2002 | WO2002072602A2 Somatostatin antagonists |
| 09/19/2002 | WO2002072596A1 Steap-related protein |
| 09/19/2002 | WO2002072191A2 Method of providing a dynamic cellular cardiac support |
| 09/19/2002 | WO2002072127A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 09/19/2002 | WO2002072116A1 Myb-transformed blood cells and their use for active ingredient screening |
| 09/19/2002 | WO2002072110A1 Caloporoside derivatives, methods for the production thereof and their use |
| 09/19/2002 | WO2002072013A2 Method of treating malignancies through induction of blood immune responses |
| 09/19/2002 | WO2002071927A2 Diagnosis and treatment of skeletal degeneration conditions |
| 09/19/2002 | WO2002055532A3 Variant growth hormone molecules conjugated with macromolecular compounds |
| 09/19/2002 | WO2002050119A3 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 09/19/2002 | WO2002041930A3 Connective tissue substitutes, method of preparation and uses thereof |
| 09/19/2002 | WO2002033119A9 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 09/19/2002 | WO2002033079A3 Human g-protein coupled receptor and uses thereof |
| 09/19/2002 | WO2002022871A3 Polymorphic bone morphogenetic protein 2 |
| 09/19/2002 | WO2002022631A3 Regulation of human pyroglutamyl peptidase-like enzyme |
| 09/19/2002 | WO2002018553A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/19/2002 | WO2002017949A9 Novel functions for dp214 |
| 09/19/2002 | WO2002014355A3 Novel mitogen activated kinase |
| 09/19/2002 | WO2002012456A3 Ampk-related serine/threonine kinase, designated snark |
| 09/19/2002 | WO2002010382A9 Trp8, trp9 and trp10, markers for cancer |
| 09/19/2002 | WO2002010379A3 Modified cea and uses thereof |
| 09/19/2002 | WO2002010362A9 Methods of controlling gene expression and gene silencing |
| 09/19/2002 | WO2002006452A3 Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli |
| 09/19/2002 | WO2002002765A3 Chimeric promoters for controlling expression in smooth muscle cells |
| 09/19/2002 | WO2002002610A3 Secretion and trafficking molecules |
| 09/19/2002 | WO2001092299A9 Adenovirus particles with mutagenized fiber proteins |
| 09/19/2002 | WO2001090188A9 Receptor-based interaction trap |
| 09/19/2002 | WO2001085956A3 Lipid metabolism enzymes |
| 09/19/2002 | WO2001083783A3 In vivo loading of mhc |
| 09/19/2002 | WO2001083729A3 Vectors for ocular transduction and use thereof for genetic therapy |
| 09/19/2002 | WO2001083514A3 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof |
| 09/19/2002 | WO2001066740A3 Compositions and methods for the treatment of immune related diseases |
| 09/19/2002 | WO2001046406A3 New qtl's on chromosomes x, 2, 6 and 7 of pigs |
| 09/19/2002 | WO2001036630A9 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 09/19/2002 | WO2001030843A9 Ligand activated transcriptional regulator proteins |
| 09/19/2002 | WO2001016342A9 Use of lentiviral vectors for antigen presentation in dendritic cells |
| 09/19/2002 | WO2001007483A9 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 09/19/2002 | WO1997046589A3 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 09/19/2002 | US20020133849 Nucleotide sequences coding enzymatic polypeptide for use in the foods, adhesives, textiles, fertilizers, medicine, cosmetics and papermaking |
| 09/19/2002 | US20020133848 Identification and characterization of an anthocyanin mutant (ANT1) in tomato |
| 09/19/2002 | US20020133847 Plant proteins |
| 09/19/2002 | US20020133845 Barstar gene |
| 09/19/2002 | US20020133836 Methods to identify swine genetically resistant to F18 E. coli associated diseases |
| 09/19/2002 | US20020133835 Genetically engineering vertebrate germ cells; obtain gonads, incubate in transfection mixture and nucleotide sequences, transfect, recover transfected germ cells |
| 09/19/2002 | US20020133235 Cell-culture and polymer constructs |
| 09/19/2002 | US20020133001 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 09/19/2002 | US20020132987 Methods and compositions for neural progenitor cells |
| 09/19/2002 | US20020132984 Polypeptide for use in the treatment of neutropenia |
| 09/19/2002 | US20020132981 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/19/2002 | US20020132979 Monoclonal antibody for use in the diagnosis, prevention and treatment of tumors |
| 09/19/2002 | US20020132978 VEGF-modulated genes and methods employing them |
| 09/19/2002 | US20020132775 Human potassium channel 1 and 2 proteins |
| 09/19/2002 | US20020132768 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/19/2002 | US20020132767 Nucleic acids, proteins, and antibodies |
| 09/19/2002 | US20020132753 Nucleic acids, proteins, and antibodies |
| 09/19/2002 | US20020132347 Genetically engineered cell for use in the diagnosis, prevntion and treatment of viral diseases |
| 09/19/2002 | US20020132346 Use of RNA interference for the creation of lineage specific ES and other undifferentiated cells and production of differentiated cells in vitro by co-culture |
| 09/19/2002 | US20020132345 To be used for high-throughput analyses |
| 09/19/2002 | US20020132344 Product and method for swelling a cell nucleus without DNA replication |
| 09/19/2002 | US20020132343 System and method for delivering umbilical cord-derived tissue-matched stem cells for transplantation |
| 09/19/2002 | US20020132342 Generating immortalized dendritic cells; obtain cells, culture, maintain culture of dendritic cells, monitor gene expression from cell culture |
| 09/19/2002 | US20020132341 Automated method, automated process control methodology, process control interface, and automated apparatus for pancretic islet isolation (separation) and processing utilizing microprocessor controller and (or) computer control of the process variables and automated apparatus including real-time process data acquisition |
| 09/19/2002 | US20020132340 Cell culture for use in the diagnosis and treatment of cancer |
| 09/19/2002 | US20020132337 Processes for preparation of marek's disease virus using continuous avian cell lines |
| 09/19/2002 | US20020132334 Nucleotide sequences coding preferential polypeptide for use in the treatment of tumors and nervous system disorders |
| 09/19/2002 | US20020132330 Polypeptide for use in the treatment, prevention and diagnosis of inflammation, cell proliferation and apoptosis |
| 09/19/2002 | US20020132324 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/19/2002 | US20020132319 Peptide mutant of human ERAB or HADH2, its X-ray crystal structure, and materials and method for identification of inhibitors thereof |
| 09/19/2002 | US20020132308 Generating gentically engineered expression vector; obtain nucleotide sequences, incubate with ligase, recover expression vector |
| 09/19/2002 | US20020132299 Production of proteins by cell culture |
| 09/19/2002 | US20020132297 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis |
| 09/19/2002 | US20020132296 Human Ste20-like stress activated serine/threonine kinase |
| 09/19/2002 | US20020132284 Methods of completing a cell culture medium with a lipophilic substance promoting the growth of cells by weight or promoting the biosynthesis of desired substances within the cells |
| 09/19/2002 | US20020132262 Nucleotide sequences coding tumor suppressor protein for use in the diagnosis and treatment of cancer |
| 09/19/2002 | US20020132253 Nucleotide sequences coding membrane protein for use in diagnosis and treatment of athersclerosis, infections, arthritis, cancer, kidney and nervous system disorders |
| 09/19/2002 | US20020132252 Nucleotide sequences coding membrane protein for use in the diagnosis and treatment of infections, arthritis, nervous system and kidney disorders, cancer and atherosclerosis |
| 09/19/2002 | US20020132240 Nucleotide sequences coding membrane proteins for use in treatment of cancer, infections, cardiavascular, nervous system, skin and kidney disorders |
| 09/19/2002 | US20020132239 Cell lineage markers |
| 09/19/2002 | US20020132237 Detecting ovarian cancer humans; obtain sample, incubate with preferential oligonucleotides, monitor hybridization, compare to control, evaluate for cancer |
| 09/19/2002 | US20020131968 An Immunoglobulin G (IgG) antibody with binding affinity for the CD3 antigen in which the heavy chain has a variable region framework together with specified complementary determining region (CDR); immunosuppressant, treating cancer |
| 09/19/2002 | US20020131962 Method of producing dendritic cells |
| 09/19/2002 | US20020131960 Eukaryotic cell expressing beta 2-microglobulin and at least one exogenous accessory molecule; used to stimulate T cells of any patient of a given human leukocyte antigen (HLA) type |
| 09/19/2002 | US20020131957 Cryopreservation of sperm |
| 09/19/2002 | US20020131956 Adeno-associated virus vectors encoding factor VIII and methods of using the same |
| 09/19/2002 | CA2441495A1 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | CA2441213A1 Cd4+cd25+ regulatory t cells from human blood |
| 09/19/2002 | CA2441182A1 Process for producing oligosaccharide chains |
| 09/19/2002 | CA2441082A1 Steap-related protein |
| 09/19/2002 | CA2440773A1 Novel mhc molecule constructs, and methods of employing these constructs for diagnosis and therapy, and uses of mhc molecules |
| 09/19/2002 | CA2440753A1 Cell-based detection and differentiation of disease states |